247 Genetics

Rosanne Ott, portfolio manager for the four star Alger Health Sciences Fund, says health care stocks will benefit during President Obama’s first 100 days in office, especially generic drug-makers Teva and Mylan.

Tags: biotech companies Obama, biotech stock, biotech stock market, biotech stock markets, biotech stock news video, biotech stock news videos, generic drug stock, generic drug stocks, healthcare stock, healthcare stock news video, healthcare stock news videos, healthcare stocks, Mylan, Obama biotech, Teva

This entry was posted on Friday, January 23rd, 2009 at 1:00 am and is filed under Barack Obama Genetics News Videos, Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.